• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Melanoma Research Alliance appoints Davisson President and CEO-elect

Melanoma Research Alliance appoints Davisson President and CEO-elect

September 11, 2015
CenterWatch Staff

The Melanoma Research Alliance (MRA) has appointed Robin L. Davisson, Ph.D., president and CEO-elect, effective Oct. 1.

Davisson, The Andrew Dickson White Professor of Molecular Physiology at Cornell University, brings to MRA more than 25 years of internationally recognized scientific research and deep engagement in graduate student and postdoctoral education and mentoring. Davisson has received some of the most prestigious research awards in her field, including the Arthur C. Corcoran Memorial Award for excellence in cardiovascular research from the American Heart Association. She was recently elected a Fellow of the American Association for the Advancement of Science. Additionally, she plays active leadership roles at various local and national nonprofit organizations.

Davisson recently served as the director of graduate studies of the Molecular and Integrative Physiology field at Cornell for seven years, and has held many other leadership positions at Cornell. Prior to joining Cornell, she was a tenured member of the faculty of the University of Iowa where she taught and researched neuroscience, cardiovascular physiology, and genomics.

Davisson’s engagement with MRA will be phased in gradually throughout 2015 and into 2016 as she fulfills her commitments at Cornell University.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing